Concepedia

Lindsay Fawcett

LF

6

Publications

655

Citations

6

H-Index

2000

Active since

Affiliations

Novartis (United Kingdom)(Current)

Lindsay Fawcett is an author at Novartis (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2000–2014

6

Publications

6

Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

Lindsay Fawcett, Rhona W. Baxendale, Peter Stacey et al. · Proceedings of the National Academy of Sciences · 2000 · 360 citations

The Influence of Receptor Kinetics on the Onset and Duration of Action and the Therapeutic Index of NVA237 and Tiotropium

David A. Sykes, Mark R. Dowling, Juliet Leighton-Davies et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 120 citations

The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35

Amanda E. Mackenzie, Gianluigi Caltabiano, Toby Kent et al. · Molecular Pharmacology · 2013 · 67 citations · Full text

Quantitative GPCR and ion channel transcriptomics in primary alveolar macrophages and macrophage surrogates

Paul J. Groot‐Kormelink, Lindsay Fawcett, Paul D. Wright et al. · BMC Immunology · 2012 · 50 citations · Full text

Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families

Eugene Gbekor, Sue Betheil, Lindsay Fawcett et al. · European Urology Supplements · 2002 · 45 citations

, , +3

Rows per page

1–5 of 6